CRH

Unlocking the Potential of CRH Stock

It's been a great morning session for CRH investors, who saw their shares rise 1.9% to a price of $89.17 per share. At these higher prices, is the company still fairly valued? If you are thinking about investing, make sure to check the company's fundamentals before making a decision.

an Increase in Expected Earnings Improves Its Value Outlook but Its Shares Are Expensive:

CRH plc, together with its subsidiaries, provides building materials solutions in Ireland and internationally. The company belongs to the Industrials sector, which has an average price to earnings (P/E) ratio of 25.19 and an average price to book (P/B) ratio of 3.17. In contrast, CRH has a trailing 12 month P/E ratio of 18.6 and a P/B ratio of 2.94.

CRH's PEG ratio is 1.24, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

Stagnant Revenue Growth With No Capital Eexpenditures:

2018 2019 2020 2021 2022 2023
Revenue (M) $27,449 $28,132 $25,888 $29,206 $32,723 $28,522
Net Margins 11% 6% 4% 9% 12% 11%
Net Income (M) $2,884 $1,717 $1,122 $2,630 $3,862 $3,206
Earnings Per Share $344.7 $2.13 $1.42 $3.32 $5.11 $4.38
EPS Growth n/a -99.38% -33.33% 133.8% 53.92% -14.29%
Free Cash Flow (M) $2,246 $3,881 $3,938 $2,425 $2,277 $4,203
Total Debt (M) $9,959 $9,211 $10,958 $9,938 $11,033 $13,401
Current Ratio 1.29 1.34 2.01 1.85 1.84 1.69
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS